Semax vs Selank — two tools, different jobs.
Both are short Russian-developed heptapeptides researched in cognitive and stress-response models. Both deliver fast via intranasal administration. They look like they should be interchangeable — they aren't. Semax pushes alertness up; Selank dials anxiety down. Different mechanisms, different timeslots, often paired in the Cognitive Stack bundle.
The short version.
Semaxis the deep-work peptide. Research subjects describe a clean, anxiety-free alertness — the kind you'd use when sitting down to write a paper or analyse a dataset. The dopaminergic + BDNF mechanism gives it a cognitive-edge profile without the stimulant after-crash.
Selankis the decision-under-pressure peptide. Almost the opposite framing — calms the GABA tone down, removes anxiety without sedating. Often described as "benzodiazepine-lite" without the dependence or cognitive fog.
Both research reference compounds — not for human consumption.
Side-by-side.
Which one fits your research?
Pick Semax alone if
- · Cognitive-edge studies: focused tasks, sustained attention, working-memory measures.
- · Pre-task model: subject performs better when alert-but-not-jittery.
- · You explicitly want dopaminergic mechanism in scope.
Pick Selank alone if
- · Stress-response models, post-stressor recovery time, anxiety-related endpoints.
- · Decision-making under load is the dependent variable.
- · You want anxiolytic effect without sedation or addictive potential.
Stack both if
- · You want the standard cognitive-protocol pair (Semax morning, Selank afternoon).
- · Research scope covers both alertness AND anxiety endpoints.
- · Cognitive Stack bundle saves ~8 % vs buying both separately.
All compounds are research reference material — not for human consumption. Questions? Email the lab.